VANGUARD GROUP INC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$104,950,241
-58.2%
11,200,666
+9.4%
0.00%
-50.0%
Q2 2023$251,196,129
+5.1%
10,240,364
-0.3%
0.01%0.0%
Q1 2023$238,923,841
-6.5%
10,267,462
+1.7%
0.01%
-14.3%
Q4 2022$255,491,820
+33.5%
10,094,501
+1.7%
0.01%
+16.7%
Q3 2022$191,420,000
-8.3%
9,928,416
+21.1%
0.01%0.0%
Q2 2022$208,784,000
+4.6%
8,197,244
+5.7%
0.01%
+20.0%
Q1 2022$199,546,000
-35.0%
7,758,397
+5.8%
0.01%
-28.6%
Q4 2021$306,913,000
-2.3%
7,330,131
+1.5%
0.01%
-12.5%
Q3 2021$314,228,000
+6.1%
7,220,317
+15.3%
0.01%
+14.3%
Q2 2021$296,079,000
-2.7%
6,262,257
+5.5%
0.01%
-12.5%
Q1 2021$304,447,000
+93.7%
5,938,114
+1.2%
0.01%
+60.0%
Q4 2020$157,201,000
-17.3%
5,870,118
+6.1%
0.01%
-16.7%
Q3 2020$189,971,000
+1188.4%
5,533,679
+1437.6%
0.01%
+500.0%
Q2 2020$14,745,000
+142.6%
359,887
+103.0%
0.00%
Q1 2020$6,077,000
+184.5%
177,320
+4.4%
0.00%
Q4 2019$2,136,000169,8690.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$30,100,00023.79%
SB INVESTMENT ADVISERS (UK) LTD 22,086,280$425,823,0003.26%
Zebra Capital Management LLC 40,104$773,0002.94%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 130,409$2,514,0000.94%
CLARK ESTATES INC/NY 180,000$3,470,0000.77%
Temasek Holdings (Private) Ltd 6,036,821$116,389,9090.70%
SECTOR GAMMA AS 89,808$1,731,0000.45%
Capital Impact Advisors, LLC 13,196$360,0000.36%
SummerHaven Investment Management, LLC 24,927$481,0000.33%
DUALITY ADVISERS, LP 92,712$1,787,0000.20%
View complete list of VIR BIOTECHNOLOGY INC shareholders